Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-19175
Publication type: | Working paper – expertise – study |
Title: | Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description |
Authors: | Eichler, Klaus Rapold, Ronald Wieser, Simon Reich, Oliver Blozik, Eva |
et. al: | No |
DOI: | 10.21256/zhaw-19175 |
Extent: | 37 |
Issue Date: | Oct-2019 |
Publisher / Ed. Institution: | ZHAW Zürcher Hochschule für Angewandte Wissenschaften |
Publisher / Ed. Institution: | Winterthur |
Language: | English |
Subjects: | Multiple myeloma; Drug treatment; Treatment patterns; Costs |
Subject (DDC): | 362.1041: Health economics 615: Pharmacology and therapeutics |
URI: | https://digitalcollection.zhaw.ch/handle/11475/19175 |
License (according to publishing contract): | CC BY 4.0: Attribution 4.0 International |
Departement: | School of Management and Law |
Organisational Unit: | Winterthur Institute of Health Economics (WIG) |
Appears in collections: | Gesundheitsökonomie |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Multiple Myeloma Drug Regimes_2019.pdf | 527.94 kB | Adobe PDF | View/Open |
Show full item record
Eichler, K., Rapold, R., Wieser, S., Reich, O., & Blozik, E. (2019). Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. https://doi.org/10.21256/zhaw-19175
Eichler, K. et al. (2019) Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description. Winterthur: ZHAW Zürcher Hochschule für Angewandte Wissenschaften. Available at: https://doi.org/10.21256/zhaw-19175.
K. Eichler, R. Rapold, S. Wieser, O. Reich, and E. Blozik, “Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description,” ZHAW Zürcher Hochschule für Angewandte Wissenschaften, Winterthur, Oct. 2019. doi: 10.21256/zhaw-19175.
EICHLER, Klaus, Ronald RAPOLD, Simon WIESER, Oliver REICH und Eva BLOZIK, 2019. Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description. Winterthur: ZHAW Zürcher Hochschule für Angewandte Wissenschaften
Eichler, Klaus, Ronald Rapold, Simon Wieser, Oliver Reich, and Eva Blozik. 2019. “Real-World Drug Regimes for Multiple Myeloma in a Swiss Population (2012 to 2017) : Cost-Outcome Description.” Winterthur: ZHAW Zürcher Hochschule für Angewandte Wissenschaften. https://doi.org/10.21256/zhaw-19175.
Eichler, Klaus, et al. Real-World Drug Regimes for Multiple Myeloma in a Swiss Population (2012 to 2017) : Cost-Outcome Description. ZHAW Zürcher Hochschule für Angewandte Wissenschaften, Oct. 2019, https://doi.org/10.21256/zhaw-19175.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.